期刊文献+

糖尿病肾脏疾病与其他慢性肾脏疾病腹膜透析患者临床特点及心血管疾病患病率和危险因素的对比分析 被引量:9

Clinical characteristics, prevalence and risk factors for cardiovascular diseases in peritoneal dialysis patients with and without diabetic kidney disease
原文传递
导出
摘要 目的比较DKD与其他慢性肾脏疾病(CKD)腹膜透析(PD)患者临床特点及心血管疾病(CVD)患病率,分析CVD发生的危险因素。方法选取2016年3月至2018年12月于新乡医学院第一附属医院肾内科PD中心规律PD 1年的患者206例。根据原发疾病是否为T2DM,将入选患者分为DKD组81例和CKD组125例,分析其临床特点及发生CVD[包括冠状动脉疾病(CAD)、左心室肥厚(LVH)和充血性心力衰竭(CHF)]与各临床指标的相关性。结果两组患者年龄、性别、BMI比较,差异有统计学意义(P<0.05)。与CKD组比较,DKD组应用高渗腹透液例数、BG、HbA1c、TG、血沉及hsC-RP水平升高(P<0.01),血浆总蛋白(TP)、白蛋白(Alb)、总胆红素(TBIL)、总尿素清除率(Kt/V)、残肾Kt/V降低(P<0.05或P<0.01)。DKD组总CVD患病率为59.26%,其中CAD患病率7.41%,LVH患病率23.46%,CHF患病率46.91%,CKD组总CVD患病率29.60%,其中CAD患病率3.20%,LVH患病率19.20%,CHF患病率24.80%。DKD组总CVD患病率及CHF患病率均高于CKD组(P<0.01)。单因素分析发现,与DKD组未发生CVD患者比较,发生CVD患者年龄大,DM病程长,TP、Alb、TBIL、HbA1c、BG、血磷、全段甲状旁腺素和hsC-RP差异均有统计学意义(P<0.05);多因素Logistic回归分析显示,Alb和TBIL水平是CVD发生的危险因素。结论 DKD腹膜透析患者存在更明显的代谢异常、更低的蛋白水平和相对明显的炎症状态,透析充分性下降,CVD患病率升高。CVD发生与Alb、TBIL水平明显降低密切相关。 Objective To investigate clinical characteristics,prevalence and risk factors for cardiovascular disease in peritoneal dialysis patients with and without diabetic kidney disease.Methods We retrospectively collected 206 patients with peritoneal dialysis in the Nephrology Department in the First Affiliated Hospital of Xinxiang Medical University from March 2016 to December 2018.All the participants were divided into two groups according to whether the renal failure was caused by T2DM:diabetic kidney disease group(DKD,n=81)and non-diabetic kidney disease group(CKD,n=125).The clinical characteristics,prevalence and risk factors for cardiovascular disease(CVD)including coronary artery disease(CAD),left ventricular hypertrophy(LVH)and congestive heart failure(CHF)were analyzed.Results There weresignificant statistical differences in age,gender and BMI between DKD and CKD group(P<0.05).The frequency of hypertonic peritoneal fluid usage,blood glucose(BG),HbA1c,triglyceride(TG),erythrocyte sedimentation rate(ESR),and hypersensitive-C reactive protein(hs C-RP)were higher in DKD group than in CKD group(P<0.01).The serum total protein(TP),albumin(Alb)levels,total bilirubin(TBIL),total Kt/V and residual Kt/V were lower in DKD group than CKD group(P<0.05 or P<0.01).The prevalence of CVD was 59.26% in DKD group,and the prevalence of CAD,LVH and CHF were 7.41%,23.46%,and 46.91%,respectively in DKD group.The prevalence of CVD was 29.60% in CKD group,and the prevalence of CAD,LVH and CHF were 3.20%,19.20%,and 24.80%,respectively in CKD group.The prevalence of CVD and CHF were much higher in DKD group than in CKD group(P<0.01).The univariate analysis showed that in DKD group,patients with CVD had an older age,longer diabetic duration,and significant difference in TP,Alb,TBIL,HbA1c,BG,phosphorus,intact parathyroid hormone and hs C-RP compared with non-CVD patients.Multiple logistic regression analysis showed that Alb and TBIL levels were risk factors for CVD.Conclusion The peritoneal dialysis patients with DKD had more significant metabolic abnormalities,lower serum protein levels,relatively obvious inflammation,lower dialysis adequacy,and higher prevalence of CVD.The occurrence of CVD was closely related to Alb and TBIL.
作者 马东红 王志信 吕玉敏 刘云 师晶晶 郭明好 MA Donghong;WANG Zhixin;LYV Yumin;GUO Minghao(Department of Nephrology,The First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2020年第12期903-910,共8页 Chinese Journal of Diabetes
基金 河南省科技厅重点研发与推广项目(182102310585) 河南省高等学校重点科研项目(17A320026) 河南省卫生厅科技攻关省部共建备选项目(2018010013)。
关键词 糖尿病肾脏疾病 腹膜透析 心血管事件 危险因素 Diabetic kidney disease Peritoneal dialysis Cardiovascular disease Risk factors
  • 相关文献

参考文献1

二级参考文献17

  • 1Kim YL. Update on mechanisms of ultrafiltration failure [J]. Perit Dial Int, 2009, 29 (Suppl 2):S123-127.
  • 2Meng XM, Chung AC, Lan HY. Role of the TGF- /BMP-7/ Smad pathways in renal diseases[J]. Clin Sci (Lond), 2013, 124(4):243-254.
  • 3Church RH, Krishnakumar A, Urbanek A, et al. Gremlinl preferentially binds to bone morphogenetic protein- 2 (BMP-2) and BMP-4 over BMP-7[J]. Biochem J, 2015, 466 (1):55-68.
  • 4Marchant V, Droguett A, Valderrama G, et al. Tubular overexpression of Gremlin in transgenic mice aggra- vates renal damage in diabetic ne phropathy[J]. Am J Physiol Renal Physiol, 2015, 309(6):F559-568.
  • 5Tomino Y. Mechanisms and interventions in peritoneal fibrosis[J]. Clin Exp Nephrol, 2012, 16(1):109-114.
  • 6L6pez Cabrera M, Aguilera A, Aroeira LS, et al. Ex vi- vo analysis of dialysis effluent- derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure[J]. Perit Dial Int, 2006, 26(1):26-34.
  • 7Wordinger RJ, Zode G, Clark AF. Focus on molecules: gremlin[J]. Exp Eye Res, 2008, 87(2):78-79.
  • 8Morrissey J, Hruska K, Guo G, et al. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function[J]. J Am Soc Nephrol, 2002, 13 (Suppl 1):S14-21.
  • 9Wang S, Chen Q, Simon TC, et al. Bone morphogenic pro- tein-7 (BMP-7), a novel therapy for diabetic nephropa-thy[J]. Kidney Int, 2003, 63(6):2037-2049.
  • 10Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counter- acts TGF-betal-induced epithelial-to-mesenchymal tran- sition and reverses chronic renal injury[J]. Nat Med, 2003, 9(7):964-968.

共引文献3

同被引文献109

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部